Parexel to acquire functional service provider ExecuPharm

By Melissa Fassbender

- Last updated on GMT

Parexel has entered into a definitive agreement to acquire ExecuPharm. (Image: iStock/Ridofranz)
Parexel has entered into a definitive agreement to acquire ExecuPharm. (Image: iStock/Ridofranz)

Related tags Pharmaceutical industry

Parexel has entered into a definitive agreement to acquire ExecuPharm, a global functional service provider (FSP), in a deal that it said will add scale to meet growing demand.

King of Prussia, PA-based ExecuPharm​ provides clients with professionals in several areas, such as clinical monitoring or study management. The company also provides support with operational activities, including onboarding, training, line management, performance management, and policy administration.

"Functional services represent an established and growing model within the biopharmaceutical industry, and ExecuPharm has supported the growing demand for these services," ​Cristi L. Barnett, senior director, global public relations, Parexel, told Outsourcing-Pharma.com, adding that both companies see "continued FSP growth opportunities​."

According to the company, ExecuPharm has seen an 85% growth over the past three years, while working with many top 20 and mid-sized and small biopharma companies.

Josef von Rickenbach, Chairman and CEO, Parexel, explained that clients are increasingly using both programmatic and functional outsourcing models, in the company's press release issued this morning. 

With its acquisition of ExecuPharm, Rickenbach said its existing functional services offering and capabilities will be expanded in order to meet the growing market demand – allowing clients to “fulfill all of their clinical development outsourcing needs through a single company​.”

The acquisition, terms of which were not released, is expected to close in the next three weeks.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars